featured
Comparison of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of Clinical Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
CALGB 80403 (Alliance)/E1206: A Randomized Phase II Study of Three Chemotherapy Regimens Plus Cetuximab in Metastatic Esophageal and Gastroesophageal Junction Cancers
J. Clin. Oncol 2016 Jul 05;[EPub Ahead of Print], PC Enzinger, BA Burtness, D Niedzwiecki, X Ye, K Douglas, DH Ilson, VM Villaflor, SJ Cohen, RJ Mayer, A Venook, AB Benson, RM GoldbergFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.